[{"NetIncomeLoss_1_Q2_USD":33500000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GeneralAndAdministrativeExpense_1_Q2_USD":43000000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":78600000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.56,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.28,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":14800000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":36500000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":36500000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q2_USD":1500000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2_Q2_USD":0.0,"FinanceLeaseLiability_0_Q2_USD":377300000.0,"Liabilities_0_Q2_USD":4637700000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":234900000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":419000000.0,"ProceedsFromLongTermLinesOfCredit_2_Q2_USD":330000000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_2_Q2_USD":3500000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":14800000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-175100000.0,"Assets_0_Q2_USD":6502500000.0,"PaymentsForSoftware_2_Q2_USD":4400000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q2_USD":36900000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q2_USD":13600000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_Q2_USD":29100000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-7800000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1200000.0,"RestrictedCashCurrent_0_Q2_USD":56400000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1100000.0,"DividendsCommonStockCash_2_Q2_USD":55900000.0,"DividendsCommonStockCash_1_Q2_USD":28000000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":3000000.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_2_Q2_USD":592500000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":100000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":15700000.0,"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_Q2_USD":94600000.0,"AssetsCurrent_0_Q2_USD":1101700000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_1_Q2_USD":0.0,"NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_1_Q2_USD":13300000.0,"NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_2_Q2_USD":33000000.0,"RepaymentsOfSeniorDebt_2_Q2_USD":11000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":553200000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":5800000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":3900000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":99600000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":38900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":99900000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":48200000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":157000000.0,"MinorityInterest_0_Q2_USD":368600000.0,"NumberOfStatesInWhichEntityOperates_0_Q2_state":39.0,"RepaymentsOfLongTermLinesOfCredit_2_Q2_USD":375000000.0,"EarningsPerShareBasic_1_Q2_USD":0.34,"EarningsPerShareBasic_2_Q2_USD":1.22,"FinanceLeasePrincipalPayments_2_Q2_USD":10900000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":11800000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_Q2_USD":46300000.0,"DebtAndCapitalLeaseObligations_0_Q2_USD":3583600000.0,"OtherAssetsNoncurrent_0_Q2_USD":305300000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-400000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":33500000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":120500000.0,"OtherAssetsCurrent_0_Q2_USD":73100000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":33400000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":120500000.0,"CostsAndExpenses_1_Q2_USD":974800000.0,"CostsAndExpenses_2_Q2_USD":1976600000.0,"SuppliesExpense_1_Q2_USD":50600000.0,"SuppliesExpense_2_Q2_USD":96300000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":253900000.0,"BusinessAcquisitionsProFormaRevenue_2_Q2_USD":2262000000.0,"BusinessAcquisitionsProFormaRevenue_1_Q2_USD":1076000000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":60700000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":119500000.0,"TreasuryStockValueAcquiredCostMethod_2_Q2_USD":4900000.0,"StockholdersEquityOther_1_Q2_USD":-300000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":48300000.0,"StockholdersEquityOther_2_Q2_USD":-2400000.0,"ShareBasedCompensation_2_Q2_USD":17000000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_1_Q2_USD":33700000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_2_Q2_USD":121100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":98700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":98500000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":251600000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":9900000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":17000000.0,"OtherCostAndExpenseOperating_2_Q2_USD":307900000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":15700000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_1_Q2_USD":100000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":195900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":60000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":3546700000.0,"Goodwill_0_Q2_USD":2318700000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":700000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":1500000.0,"IncomeLossFromDiscontinuedOperationsNetOfTax_2_Q2_USD":0.0,"RestrictedCashNoncurrent_0_Q2_USD":14600000.0,"OtherCostAndExpenseOperating_1_Q2_USD":148300000.0,"AccountsPayableCurrent_0_Q2_USD":93100000.0,"NetIncomeLoss_2_Q2_USD":120500000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2041400000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":5300000.0,"NumberOfOperatingSegments_2_Q2_segment":2.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":1831400000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":33500000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":120500000.0,"LiabilitiesCurrent_0_Q2_USD":664400000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-20000000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":56700000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":0.34,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":1.21,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":455800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":490000000.0,"InterestExpense_1_Q2_USD":45800000.0,"InterestExpense_2_Q2_USD":89000000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q2_USD":5400000.0,"EarningsPerShareDiluted_1_Q2_USD":0.34,"EarningsPerShareDiluted_2_Q2_USD":1.21,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":6502500000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-9100000.0,"IncreaseDecreaseInAccruedSalaries_2_Q2_USD":58400000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":4900000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1074100000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":2256100000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":1100000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":42200000.0,"LitigationSettlementExpense_1_Q2_USD":0.0,"PartnersCapitalAccountContributions_2_Q2_USD":24700000.0,"PartnersCapitalAccountContributions_1_Q2_USD":18900000.0,"IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_1_Q2_USD":14800000.0,"IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_2_Q2_USD":36500000.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q2_USD":33400000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":11100000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":268500000.0,"LitigationSettlementExpense_2_Q2_USD":2800000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_Q2_USD":0.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q2_USD":100000.0,"ProfitLoss_1_Q2_USD":48300000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_2_Q2_USD":400000.0,"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_2_Q2_USD":-100000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":38500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":330400000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":0.34,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":1.22,"NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_2_Q2_USD":153500000.0,"NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_1_Q2_USD":46800000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-80000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":166600000.0,"PaymentsToMinorityShareholders_2_Q2_USD":37400000.0,"StockholdersEquity_0_Q2_USD":1462800000.0,"OtherLiabilitiesCurrent_0_Q2_USD":492200000.0,"LaborAndRelatedExpense_1_Q2_USD":651900000.0,"LaborAndRelatedExpense_2_Q2_USD":1331000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":191700000.0,"ProfitLoss_2_Q2_USD":157000000.0,"PaymentsOfDistributionsToAffiliates_2_Q2_USD":162300000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":157000000.0,"Ticker":"EHC","CIK":"785161","name":"ENCOMPASS HEALTH CORP","OfficialName":"Encompass Health Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"7151596423.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20200731"}]